Number of Shares
12,000.00
Current Holdings Value*
$711,000.00
% of Portfolio
8.6%
Total Estimate Gain
$6.05 Mil
% of Total Estimate Gain
168.43%

Copernicus Capital Management, LLC's Fate Therapeutics Inc Holding Summary

As of 2021-09-30, Copernicus Capital Management, LLC held 12,000.00 shares of Fate Therapeutics Inc(FATE), totaling $711,000.00. This investment constitutes 8.6% of their stock portfolio, and Copernicus Capital Management, LLC now holds 0.01% of the outstanding Fate Therapeutics Inc(FATE) stock.

The initial trade took place in 2019Q3. And since then Copernicus Capital Management, LLC has made 5 purchases of FATE, at an average price of $21.05, for a total of 170,737.00 shares. In addition, there have been 4 sales at an average price of $60.69 for 158,737.00 shares. Based on historical transaction data and FATE's current price of $1.24, Copernicus Capital Management, LLC's estimated gain on his FATE holdings is $6.05 Mil, reflecting a 168.43% gain to date.

Copernicus Capital Management, LLC FATE ($1.24) Holding Chart

Copernicus Capital Management, LLC FATE ($1.24) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1